medical and healthcare business awards 2018...medical and healthcare business awards 2018 medilink...

MEDILINK WEST MIDLANDS

MEDICAL AND HEALTHCARE BUSINESS AWARDS 2018

MEDILINK WEST MIDLANDS

FEBRUARY 2019

Celebrating the best in life science and healthcare

MEDICAL AND HEALTHCARE BUSINESS AWARDS FEBRUARY 2019

2 3

WELCOME

The winners of the 2018 Medilink West Midlands (Medilink WM) Medical and Healthcare Business Awards have been revealed. The Awards, which have been running for over 10 years, took place on Thursday 7th February at The Birmingham Conference and Events Centre.

The annual Medical and Healthcare Business Awards celebrate the outstanding contributions, innovations and achievements to life sciences across the West Midlands, with winners going on to represent the region at the national Medilink UK Awards.

The headline sponsor for this year’s Awards was Medilink West Midlands Patron, MasterControl.

Richard Stone, CEO, Medilink West Midlands, said: “The 2018 Medilink West Midlands Awards have been a great success, and I would like to offer my congratulations to all the winners and finalists.

“It’s been great to see and to celebrate all the outstanding contributions and exceptional work across the West Midlands life sciences sector in the last year.

“Thank you to everyone who entered, and congratulations to our winners. We would like to wish them the very best of luck at the Medilink UK Awards in May.”

Congratulations to our 2018 Medical and Healthcare Business Award winners

(L-R) Richard Stone, CEO (Medilink West Midlands); John Foskett, Director (Grant Thornton UK LLP)

FEBRUARY 2019

54

Winners across the Start-up, Innovation,

Partnership with the NHS, and Outstanding

Achievement award categories, along with

regional Medilink award winners from around the UK, will

now be entered into the national Medilink UK Awards in May, held in

association with Med-Tech Innovation. The 2018 Award winners were as follows:

Start-up Award (sponsored by Calthorpe Estates)

Winner: Orthocell UK – Orthocell is a regenerative medicine company producing cellular therapies, and collagen scaffolds for the treatment of human tissue injuries and defects.

Innovation Award (sponsored by Marks & Clerk)

Winner: The Tinnitus Clinic Ltd – The Tinnitus Clinic are an adult audiology rehabilitation provider. They have created an online Sound Matching Tool for potential patients to self-test their tinnitus tone.

Partnership with the NHS Award (sponsored by West Midlands Academic Health Science Network)

Winner: B13 Technology Ltd – B13 Technology use technology to help businesses investigate challenging ideas and discover disruptive thinking.

Supply Chain Award (sponsored by MasterControl Inc.)

Winner: Evolyst Ltd – Evolyst specialise in the development of patient-centred health technology solutions. Their current focus is tackling mental health, breaking down the stigma behind it and ensuring everyone has access to the right platforms.

Outstanding Achievement Award (sponsored by Medilink Midlands)

Winner: Kimal PLC – Kimal is an innovative manufacturer and supplier of specialised procedure packs and vascular access devices to hospitals across the world.

OURWINNERS2018 MEDILINK WM AWARDS

Our Awards celebrate the best in life sciences and healthcare across the West Midlands region.


6 7

Our thanks go to MasterControl, our 2018 Medilink West Midlands Medical and Healthcare Business Awards Headline Sponsor, as well as our Award Sponsors for all of their support in helping to make our 2018 Awards such a memorable event!

Calthorpe Estates, our Start-up Award sponsor

Marks & Clerk, our Innovation Award sponsor

West Midlands Academic Health Science Network (WMAHSN), our Partnership with the NHS Award sponsor

MasterControl, our Supply Chain sponsor

Medilink Midlands, our Outstanding Achievement Award sponsor

We’d also like to extend our gratitude to Mark Tolliss, our Compère for the evening, and Darius Electric Violinist for providing such amazing entertainment for the night!

THANK YOU TO ALL OUR SPONSORS!

We would like to say a big thank you to all of our sponsors this year

ORTHOCELL UK

”


8 9

START-UP AWARD

Congratulations to our 2018 Start-up Award winner, Orthocell UK.

Orthocell have developed an exclusive partnership with Carrera Medical in the marketing of CelGro®, a Collagen Membrane and a significant new product for aiding quicker bone growth in dental surgery.

Orthocell UK, along with the team at Carrera, have certainly announced their entry into the UK market. They are members of the ADI Dental Association of the UK and in addition to treating patients in the public and private markets, they are engaged in discussions for future research programmes with cinicians.

Orthocell UK have made an encouraging start to penetrating the European dental market, and are predicting significant growth over the next 3 years.

“We were honoured for Orthocell to be considered for the best start-up company in life sciences in the West Midlands for the 2018 Medilink WM awards. As we have only been trading in the UK for a short peri-od of time we feel privileged to have won the Award and this has justified our belief in the qualities and innovation of the CelGro Collagen Membrane as well as the exceptional work of our team at Orthocell.

The staff at Medilink, WMAHSN and DIT deserve recognition for their assistance in detailing pathways within the Healthcare sector to assist new companies such as Orthocell grow their investment in the UK. Their continued direction and assistance is fundamental to our ongoing success. - Kevin Edwards, European Manager, Orthocell UK

Celebrating newly established companies (trading for up to 3 years) in the medical and healthcare sector, that show a promising future.

Sponsored by Calthorpe Estates

(L-R) Katie Judge, Executive Manager for Business & Innovation (The Greater Birmingham and Solihull Local Enterprise Partnership);

Kevin Edwards, European Manager (Orthocell UK)

INNOVATION AWARD

Our 2018 Innovation Award went to The Tinnitus Clinic Ltd.

The Tinnitus Clinic is an adult audiology rehabilitation provider with clinics across the UK, who specialise in tinnitus and hyperacusis, both distressing long-term conditions.

The Tinnitus Clinic leads the world in introducing innovative tinnitus treatments to the market place, which are likely to bring benefit to the tinnitus population.

The company has created an online tool for potential patients to self-test their tinnitus tone, unique in its use in supporting pre-appointment thought patterns of the patient.

Identifying what their sound is like, can help a patient describe their condition to both their friends and families and to the clinician, involving the patient in their diagnosis at a very early stage.

“The self-diagnosis tool came about because we are acutely aware that describing tinnitus to either a professional or a close friend or family, is difficult if not impossible for people. This simple tool means that our audiologist has some advance notice of the type of sound the patient is experiencing , therefore giving the tool a clinical purpose. But importantly, it gives the patient ownership of the description and can alleviate anxiety simply because it gives them a language to describe the sound aspect of their symptoms.

“We continue to get excellent results for our tinnitus patients from our selection of evidence based treatments, and we will continue to search for new treatments which we hope can be more accessible to all patients, across all areas of health care.

“Thank you again, The Tinnitus Clinic is really proud to have won this award.- Josephine Swinhoe, Director , The Tinnitus Clinic

For the development of an innovative technology, design or process that has produced a major improvement in business performance or end-user benefit.

Sponsored by Marks & Clerk TINNITUS CLINIC

”


10 11

(L-R) Florian Bazant-Hegemark, Chartered (UK) and European PatentAttorney (Marks & Clerk); Philip Cupitt, Chartered (UK) and European

Patent Attorney (Marks & Clerk); Lucy Chatwin, Head of Innovation, Implementation and Adoption (West Midlands

Academic Health Science Network)

PARTNERSHIP WITH THE NHS AWARD

Our Partnership with the NHS Award this year went to innovative tech and software development company, B13 Technology.

B13 Technlogy pride themselves on using technology to help businesses go further, break new ground, investigate challenging ideas and discover disruptive thinking.

B13 have a global reach, managing an international workforce from their UK base to deliver faster and for better value.

From software development to websites, apps, and system integration, and whether it’s a start-up dipping their toe in the digital waters or a brand looking to push innovation to its limits, the company’s agile, scalable service can fit.

With strong personal relationships, technical expertise, attention to detail and ultimate accountability, clients can trust B13 Technlogy to take them where they want to be.

“B13 Technology are very proud to win the Partnership with the NHS Award at the Medilink Business Awards.

“B13 are an innovative and disruptive software development consultancy that as well as developing mobile and web applications, also leverage deep technology such as augmented reality and artificial intelligence. We have been knocking at the NHS’s door for over 5 years, knowing that we can deliver commercially minded solutions, bring fresh thinking and find efficiencies for our national treasure.

“This award goes to show that we are making great inroads and have demonstrated what we are capable of. To get the support and recognition of our peers means an awful lot to all of us and we hope that we are able to help more clinicians innovate and bring new ideas to market.- Jon Swinbourne, Operations Director, B13 Technology

Celebrating collaboration with the NHS that has had or will create a major impact or benefit to business performance and patient care.

Sponsored by West Midlands Academic Health Science Network (WMAHSN)

B13 TECHNOLOGY

”


12 13

(L-R) Clare Streets, Associate Director (B13 Technology), Doug Ward, Associate Director (B13 Technology); Tammy Holmes, Innovation

Exchange Lead (West Midlands Academic Health Science Network)

SUPPLY CHAIN AWARD

Congratulations to our 2018 Supply Chain Award Winner, Evolyst.

Evolyst specialise in the development of patient-centred health technology solutions that improve business and patient outcomes, increase overall revenue and make a real difference to health and well-being. Their current focus is tackling mental health, working towards breaking down the stigma behind poor mental health and ensuring everyone has access to the right platforms.

Evolyst is currently working alongside Adjust4Work Ltd to develop an occupational health adjustment tool that allows users to improve their occupational health.

We spend over 1/3 of our lives in the workplace, and many health problems arise from poor well-being at work. This platform is a major step in creating positive change.

‘Adjust4Work’, is an occupational health adjustment platform where users can insert their conditions, environment and work activities to get a list of related workplace adjustments in the form of an occupational health document. The platform automatically generates positive adjustments based on user entries and allows users to track their changes over time.

The platform is developed for employers who wish to support their employees’ wellbeing, providing them with the knowledge to make the necessary adjustments to get their staff back to work and prevent further issues.

“Evolyst have made a major positive impact on our business. They have produced a minimum viable product that is customer ready in a short space of time, on a tight budget. Evolyst have grown our business and improved our market share. - Adjust4Work Ltd

For excellence in overall supply chain operations and consultancies and the impact made through services supplied to business clients.

Sponsored by MasterControl Inc. EVOLYST

”


14 15

(L-R) Luke Byerley, Marketing Coordinator; Eddie Carter, Quality Assurance Apprentice; Prince Mannix, Product Owner (Evolyst); Stephen

Turnock, Sales Director EMEA (MasterControl); Ben Skirth, Company Director; Christopher Golby, Director (Evolyst)

OUTSTANDING ACHIEVEMENT AWARD

We were delighted to award our Outstanding Achievement Award this year to Kimal.

Kimal is an innovative and trusted manufacturer and supplier of specialised procedure packs and vascular access devices to hospitals across the world.

The company is dedicated to exceeding customer expectations and they have been able to build a niche capability focused on the service their support teams offer and a customised logistics solution suitable for individual customer requirements.

Alan Press, son of founder the late George Press, celebrated his 40th year with Kimal in 2018. Alan has built an impressive network of influential companies, clinicians and researchers over the years, from Sales Manager to MD, all the way through to Executive Chairman.

Alan has been instrumental in getting the company to where it is today and Kimal is still trading on relationships Alan built over 30 years ago.

“At the heart of Kimal is our passion for delivering innovative solutions and exceeding our customers’ expectations. Alan is that heart and keeps it beating with enthusiasm and a pride to do everything within his power to help anyone who finds themselves in hospital and in contact with a Kimal product.”

In December 2018, Kimal received the keys to their new purpose built 144,000sq ft warehousing facility, doubling the size of the existing site.

“This shows that Kimal still has great prosperity and solid plans for future growth and with this level of investment, including a new dedicated catheter manufacturing facility, the only thing for certain is that Kimal is not resting on its laurels.- Steve Minett, R&D Project Manager, Kimal PLC

Celebrating outstanding achievements that has had a significant or vital impact on the company.

Sponsored by Medilink Midlands KIMAL

”

“

”


16 17

At the heart of Kimal is our passion for delivering innovative solutions and exceeding our customers’ expectations.

Steve MinettKimal PLC

Steve Minett, R&D Project Manager - Medical Devices ( Kimal PLC)

18

We also want to give a very special

announcement to Sensus Group and

Bitjam, who were awarded with the title

“Ones to Watch” in the Start-up and Partnership with

the NHS categories, respectively. We look forward to seeing them

progress in the future.

Start-up Award (sponsored by Calthorpe Estates)

‘Ones to watch’: Sensus Group Ltd – Founded in 2017, Sensus Group offer specialist consultancy, training and resource in delivering and implementing compliance of the new EU Medical Device (EUMDR 2017/745) and In-Vitro (IVDR 2017/746) Regulations.

Due to the new regulations and pending Brexit, Sensus Group have extended their market service offering to EU Authorised Representation, based out of offices in Dublin, Ireland.

From their beginnings in 2017, Sensus have engaged with over 30 companies, from SME to Blue Chip (top 10 Med Dev and IVD). In the future, they plan to engage with more UK and non-EU based companies and to represent them as EU Authorised Representatives.

‘ONES TO WATCH’2018 MEDILINK WM AWARDS

Our Awards celebrate the best in life sciences and healthcare across the West Midlands region.

Partnership with the NHS Award (sponsored by West Midlands Academic Health Science Network)

‘Ones to watch’: Bitjam Ltd – Bitjam has developed innovative healthcare technologies that are proving to drive positive change in Australia, USA and across the EU.

Bitjam and Combined Healthcare worked with patients diagnosed with mild cognitive impairments (a precursor to vascular dementia). The BeAble System, developed in partnership with the Trust, is an app which focuses on key principles of good self-care and self-efficacy, including behaviour activation and tailored medical information.

FEBRUARY 2019

1918

(L-R) Tammy Holmes, Innovation Exchange Lead (West Midlands Academic Health Science Network); Jacob Gawlik,

Web Development Lead (Bitjam Ltd)

(L-R) Ben Jaggers, Managing Director (Sensus Group Ltd); VanessaBailey, Events Coordinator (Medilink West Midlands)Mark Tolliss, Compère

Our 2018 Award Winners and ‘Ones to Watch’ from Orthocell UK, Evolyst Ltd, B13 Technology Ltd, Kimal PLC, and Sensus Group Ltd.

OUR WINNERSCongratulations to all our 2018 Medilink WM Award winners!

Kimal expands its

distribution facilities due

to unprecedented growthKimal Holdings Ltd., is an innovative manufacturer of customised procedure packs and vascular access devices to clinical departments across the world. Last month saw Kimal Holdings Ltd., take ownership of its brand new, purpose built distribution facility at the Worcester Six business park.

Last month saw Kimal Holdings Ltd. take ownership of its brand new, purpose built distribution facility at the Worcester Six business park off of Junction 6 of the M5 Motorway, 25 miles south west of Birmingham. Kimal’s Droitwich-based facility will subsequently close this month, with the team completing their transfer to Worcester Six by the end of March.

Kimal Holdings Ltd., is an innovative manufacturer of customised procedure packs and vascular access devices to clinical departments across the world. It all started in 1964, when Kimal began distributing products for well-known companies such as Cordis; and since then, the Company has grown, manufacturing over 2 million procedure packs and medical devices every year for a range of specialities; and its unique, ground-breaking central venous catheter technology is helping to reduce patient risk in hospitals across the world.

In 2015 it was decided that, due to the unprecedented growth that Kimal had experienced over the previous 5 years, and the subsequent outgrowing of capacity, investment in a new,

larger distribution facility was required. Kimal Holdings Ltd., therefore invested £3 million in the company’s new Worcester Six facility, which covers 140 sq. ft. There are also plans for a further £3 million investment at a later date.

With this new distribution facility, Kimal can continue to achieve double digit growth and it is hoped that with the company’s Worcester Six site now complete, Kimal can achieve its ambitious strategic objectives over the next 5 years.

Medilink memberKimal


22 23

By Medilink memberBarker Brettell

Membership NewsMEDICAL AND HEALTHCARE BUSINESS AWARDS FEBRUARY 2019

24 25

What were the final items you picked up before leaving home this morning? Chances are that it was your keys. And a smartphone. In 20 years the smartphone has become almost indispensable, helping us in many areas of our lives. It is no longer a device just to call and text: you could argue that it’s a pocket office, replacing the need for a laptop; an entertainment portal, superseding the MP3 player; and a GPS navigation aid which has widely replaced stand-alone Sat-Navs. And then there are the thousands of apps to choose from, enabling us to further personalise the smartphone’s function.

Is it only a matter of time before the smartphone is an integral part of our healthcare regime too?

To date, the number of mobile applications categorised as ‘healthcare’ exceeds 45,000 on both the App Store and Google Play. And after a few years promoting several other health apps, the NHS will be launching its own in December 2018.

So on a practical level, how will the new app benefit patients? It could be as simple as being able to FaceTime a doctor. Telemedicine is a

growing sector, which the NHS is beginning to capitalise on (the official service, GPatHand, is currently restricted to London). Telemedicine takes advantage of the smartphone’s video, audio and GPS capabilities, and may help to reduce waiting times – as well as allowing access to GPs and specialists for those that are unable to travel to appointments.

Again at the lower end of the technological spectrum, the smartphone can be used as a portable reference database – the majority of medical apps on various ‘top ten’ lists are reference apps. As well as exposing the layman to a world of self-diagnosis, these apps can enable a health professional to travel to a patient and still access all of the necessary information.

One area where technology has already significantly transformed healthcare is in the monitoring and treatment of chronic illnesses such as diabetes. 30 years ago, a patient would be checking blood sugars with a urine dipstick and estimating approximate levels against a colour chart. Now, a patient can swipe their mobile over a

sensor in the upper arm and see the last eight hours of data, utilising the NFC capabilities of the more recent smartphones.

This kind of technology (smartphone-as-measuring device) could be, and is being, applied to many different fields. For example, a smartphone can monitor sleep quality using the built-in microphone and/or accelerometer. Simply placing the index finger on the camera can give an instant measurement of the heart rate by detecting a colour change in the finger when the heart beats – like the pulse oximeter found in hospitals.

Self-treatment and diagnosis is on the up and it is difficult to see this slowing any time soon. The smartphone is likely to play a key role in this, especially with the upcoming launch of the NHS app.

For the time being, the app has fairly basic functionality – patients can access their records, order repeat prescriptions and access 111 – all things that can be done over the phone. But the app has the potential to be much more powerful than this.

Perhaps in the future a patient may be able to photograph an injury or blemish and submit it with a few key words within an app. The app could then take advantage of image analysis software and a database stored on the smartphone to determine the most likely issue and remedy, without requiring the input of a professional and without any burden on the NHS.

So how can the intellectual property in these apps be protected? A large number of healthcare and medical apps currently available are reference guides, medication reminders or information logs. On a basic level, these apps would be excluded from patentability because they lack technical subject matter – they are likely to fall under the presentation of information, business method or method of diagnosis exclusions.

However, it is not impossible to patent a healthcare-related app, particularly if the app forms part of a system (such as with a blood pressure or heart rate monitor). Another option to protect an app could be by registering a design or a trade mark, as discussed here in a previous article.

Barker Brettell has a dedicated medical sector group. If you would like to discuss options for protecting your new invention (app or otherwise) please get in touch with one of the team, or contact your usual attorney.

www.barkerbrettell.co.uk

YOUR IPHONE WILL SEE YOU NOW

https://www.gov.uk/government/news/new-nhs-app-will-make-it-quicker-and-easier-to-access-health-services

https://www.barkerbrettell.co.uk/registered-design-protection-just-click-away-apps/

https://www.barkerbrettell.co.uk/our-sectors/medical/

http://www.barkerbrettell.co.uk

MasterControl were delighted to sponsor the Medilink West Midlands Awards Dinner on 7th February and to be a part of this prestigious event bringing together the best in healthcare and life sciences across the region. Congratulations to all the winners and runners up. It’s great to see Medical Device companies coming together to support each other in the life science industry and striving to make a difference. We look forward to partnering with Medilink West Midlands in 2019 on specific events.

MasterControl provides a full line of industry‐specific quality and compliance software solutions and services for organisations of all sizes. Our integrated solution allows you to track and manage all of the individual quality processes that are critical to regulated companies in one seamless environment, enabling you to accelerate compliance and get to market faster. For more information visit www.mastercontrol.com.

Stephen TurnockMasterControl

”

“


26 27

Brexit and the need of an EU authorised representative for

UK medical devices

Membership NewsMEDICAL AND HEALTHCARE BUSINESS AWARDS FEBRUARY 2019

28 29

Of course all this is may be conjecture – and listening to the news may not help – but it looks like after the 29th March 2019 deadline an EU based Authorised Representative (EC Rep) will be needed if UK device businesses export devices to markets where a CE mark is required.

However, if a deal is struck between the EU and the UK, and it is passed by UK Parliament, an implementation period should commence allowing UK manufacturers until 31st December 2020 to continue to supply CE marked devices into the UK market as an alternative to the new proposed MHRA registration.

If they want to continue to sell into the EU, and other markets that demand the CE mark, they will need to appoint an EC Rep. This will need changes to technical information, including, but not limited to, packaging, product labels, IFU’s, brochures, CE Certificate, and Declarations of Conformity - in places where you would be expected to indicate the name and address of an EU based EC Rep.

In the event that UK Parliament votes against a deal that has been agreed between the EU and UK Government the UK could leave the EU immediately. This would mean no implementation period and the EU may not commit to a transition period. Therefore UK device manufacturers could potentially be locked out of the EU until such time that they have appointed an EU based EC Rep and updated device registrations. Therefore the 29th March 2019 could be a critical date.

UK manufacturers should be prepared to move quickly in the event of a no deal Brexit and even if a deal is struck there is no guarantee that EU Competent Authorities, or non UK customers, will accept CE marked devices after any UK only transition period.

Consultants, and particularly Advena Ltd (www.advernamedical.com) who have a second EU address, are available help to assure continuity with an EC Rep based in the EU.

By Medilink memberAdvena

http://www.advernamedical.com

Whether you like it or not, you should brace yourself for Industry 5.0. The term refers to people working alongside robots and smart machines. If that definition brought to mind the image of Will Smith battling evil robots in the movie “I, Robot,” here are a few things you need to know about Industry 5.0.

While science fiction is full of bad machines trying to kill humans or take over the world, in reality, robotics is practical. Think Roomba, the vacuum cleaner, and LoweBot, the robot that helps find or scan products in Lowe’s home improvement stores.

Industry 5.0 is about robots making humans work better and faster. It refers to the necessary interaction between people and machines. In the manufacturing world, robots usually perform monotonous work, such as welding and painting in car factories and loading and unloading heavy materials in warehouses.

The Danish company Universal Robots is the first to manufacture industrial robots that literally work alongside humans. Whereas most industrial robots

work behind safety caging, the company’s robots were first deployed alongside people in 2008.

3 Things to Remember

To understand Industry 5.0, here are three things you need to remember.

#1 Industry 5.0 is about humans, not robots.Robots are designed to help humans and make our lives better. Universal Robots uses the term “cobots” for collaborative robots to emphasize the importance of people in robotic technology.

“Industry 5.0 will make the factory a place where creative people can come and work, to create a more personalized and human experience for workers and their customers,” said Esben Østergaard, Universal Robots chief technology officer and co-founder, in an article published on Enterprise IoT Insights.

He thinks consumers will increasingly demand craftsmanship and personalization of products. Through automation and cobots, the manufacturing process can be streamlined to allow humans to create something special and unique. The use of robots will actually bring back the human factor to manufacturing, according to Østergaard.

#2 Industry 5.0 is meant to optimize human efficiency and productivity.Industry 4.0 is about the interconnectedness

of machines and systems for optimal performance. Industry 5.0 takes such efficiency and productivity further by honing the interaction between humans and machines.

A combined human and robot workforce will call for a new executive role, the chief robotics officer (CRO), who will be responsible for planning and managing all activities related to robotics and intelligent operational systems. A report by Myria Research forecasted that by 2025, more than 60 percent of manufacturing, logistics and supply chain, agri-farming, and the oil, gas and mining sectors will have CROs.

#3 Industry 5.0 is inevitable.When it comes to technology, there’s no turning back. The European Economic Social Committee (EESC) said it best: “The proliferation of robotic automation is inevitable.”

The committee, a European Union (EU) consultative body, acknowledged that Europe lagged behind the United States and China in artificial intelligence, and called for acceleration of artificial intelligence (AI) and robotics development in the region. “The EU should embrace digitalisation wholeheartedly for the sake of consumers, manufacturers, and employees alike,” it said.

The full article is available here. www.mastercontrol.com/gxp-lifeline/3-things-you-need-to-know-about-industry-5.0

By Medilink WM PatronMasterControl

3 THINGS YOU NEED TO KNOW ABOUT INDUSTRY 5.0

Membership News


30 31

https://www.mastercontrol.com/gxp-lifeline/3-things-you-need-to-know-about-industry-5.0


32 33


34 35

MEDILINK WM

4 Greenfield Crescent, Edgbaston, Birmingham B15 3BE

www.medilinkwm.co.uk

0121 452 5630

@MedilinkWM

@MedilinkUK

medical and healthcare business awards 2018...medical and healthcare business awards 2018 medilink...

Documents